Jazz Pharmaceuticals PLC (NAS:JAZZ)
$ 121.58 -0.01 (-0.01%) Market Cap: 7.35 Bil Enterprise Value: 10.93 Bil PE Ratio: 17.12 PB Ratio: 1.76 GF Score: 85/100

Jazz Pharmaceuticals PLC at Wells Fargo Healthcare Conference Transcript

Sep 08, 2022 / 03:00PM GMT
Release Date Price: $151.55 (-0.30%)
Jacob William Hughes
Wells Fargo Securities, LLC, Research Division - Senior Analyst

Hi, everyone. We're going to go on to the next session. My name is Jacob Hughes. I'm the senior specialty pharmaceutical analyst at Wells Fargo Securities.

I'm extremely pleased to have the entire Jazz team here today. We have Kim, Renee and Rob here. I think this is a really exciting time for Jazz as they've built out the pipeline, delevered the balance sheet and have announced some 2025 targets. So I'm going to hand it over to Renee to give a brief intro, and then we'll jump into Q&A. And through the conversation, if you have additional questions, please chime in.

Renee D. Gala
Jazz Pharmaceuticals plc - Executive VP & CFO

Great. Thanks, Jake, and thank you for having us. We're thrilled to be here. Just briefly before we get started, we will be making forward-looking statements today. These are all subject to risks, and please see our SEC filings for more information.

Also, we may reference non-GAAP financial measures. Full reconciliations are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot